These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2849487)

  • 21. Type V osteogenesis imperfecta: a new form of brittle bone disease.
    Glorieux FH; Rauch F; Plotkin H; Ward L; Travers R; Roughley P; Lalic L; Glorieux DF; Fassier F; Bishop NJ
    J Bone Miner Res; 2000 Sep; 15(9):1650-8. PubMed ID: 10976985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteogenesis imperfecta: an expanding panorama of variants.
    Sillence D
    Clin Orthop Relat Res; 1981 Sep; (159):11-25. PubMed ID: 7285446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteogenesis imperfecta at the beginning of bone and joint decade.
    Primorac D; Rowe DW; Mottes M; Barisić I; Anticević D; Mirandola S; Gomez Lira M; Kalajzić I; Kusec V; Glorieux FH
    Croat Med J; 2001 Aug; 42(4):393-415. PubMed ID: 11471191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
    Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
    Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.
    Gajko-Galicka A
    Acta Biochim Pol; 2002; 49(2):433-41. PubMed ID: 12362985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations.
    Garnero P; Schott AM; Prockop D; Chevrel G
    Bone; 2009 Mar; 44(3):461-6. PubMed ID: 19071236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteogenesis imperfecta: changes in noncollagenous proteins in bone.
    Vetter U; Fisher LW; Mintz KP; Kopp JB; Tuross N; Termine JD; Robey PG
    J Bone Miner Res; 1991 May; 6(5):501-5. PubMed ID: 2068957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The developmental stages of osteoblast growth and differentiation exhibit selective responses of genes to growth factors (TGF beta 1) and hormones (vitamin D and glucocorticoids).
    Lian JB; Stein GS
    J Oral Implantol; 1993; 19(2):95-105; discussion 136-7. PubMed ID: 8246305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteogenesis imperfecta: biochemical studies of bone collagen.
    Fujii K; Tanzer ML
    Clin Orthop Relat Res; 1977 May; (124):271-7. PubMed ID: 598086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis.
    Hilal G; Martel-Pelletier J; Pelletier JP; Ranger P; Lajeunesse D
    Arthritis Rheum; 1998 May; 41(5):891-9. PubMed ID: 9588742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
    Land C; Rauch F; Travers R; Glorieux FH
    Bone; 2007 Mar; 40(3):638-44. PubMed ID: 17127117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients.
    Ries-Levavi L; Ish-Shalom T; Frydman M; Lev D; Cohen S; Barkai G; Goldman B; Byers P; Friedman E
    Hum Mutat; 2004 Apr; 23(4):399-400. PubMed ID: 15024745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous pamidronate in osteogenesis imperfecta type VII.
    Cheung MS; Glorieux FH; Rauch F
    Calcif Tissue Int; 2009 Mar; 84(3):203-9. PubMed ID: 19137231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteogenesis imperfecta: clinical, cephalometric, and biochemical investigations of OI types I, III, and IV.
    Jensen BL; Lund AM
    J Craniofac Genet Dev Biol; 1997; 17(3):121-32. PubMed ID: 9338855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mild dental findings associated with severe osteogenesis imperfecta due to a point mutation in the alpha 2(I) collagen gene demonstrate different expression of the genetic defect in bone and teeth.
    Luder HU; van Waes H; Raghunath M; Steinmann B
    J Craniofac Genet Dev Biol; 1996; 16(3):156-63. PubMed ID: 8872706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanical properties of OI type III bone tissue measured by nanoindentation.
    Fan Z; Smith PA; Eckstein EC; Harris GF
    J Biomed Mater Res A; 2006 Oct; 79(1):71-7. PubMed ID: 16758461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thirty-three novel COL1A1 and COL1A2 mutations in patients with osteogenesis imperfecta types I-IV.
    Ward LM; Lalic L; Roughley PJ; Glorieux FH
    Hum Mutat; 2001 May; 17(5):434. PubMed ID: 11317364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Morphofunctional aspects of genetic analysis of osteogenesis imperfecta in cultured skin fibroblasts].
    Meerson EM; Barer FS; Berezhnyĭ AP; Prokhorova EV; Maliavko TP; Chernysheva EV; Neustroeva EP
    Biull Eksp Biol Med; 1992 Jul; 114(7):86-8. PubMed ID: 1421323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased intra-cortical porosity reduces bone stiffness and strength in pediatric patients with osteogenesis imperfecta.
    Vardakastani V; Saletti D; Skalli W; Marry P; Allain JM; Adam C
    Bone; 2014 Dec; 69():61-7. PubMed ID: 25238898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered cytoskeletal organization characterized lethal but not surviving Brtl+/- mice: insight on phenotypic variability in osteogenesis imperfecta.
    Bianchi L; Gagliardi A; Maruelli S; Besio R; Landi C; Gioia R; Kozloff KM; Khoury BM; Coucke PJ; Symoens S; Marini JC; Rossi A; Bini L; Forlino A
    Hum Mol Genet; 2015 Nov; 24(21):6118-33. PubMed ID: 26264579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.